Clovis Oncology Inc (NASDAQ:CLVS)

0.7199
Delayed Data
As of May 20
 +0.0066 / +0.93%
Today’s Change
0.66
Today|||52-Week Range
7.24
-73.44%
Year-to-Date

Stock Price Forecast

The 2 analysts offering 12-month price forecasts for Clovis Oncology Inc have a median target of 3.50, with a high estimate of 4.00 and a low estimate of 3.00. The median estimate represents a +386.18% increase from the last price of 0.72.

Analyst Recommendations

The current consensus among 3 polled investment analysts is to Hold stock in Clovis Oncology Inc. This rating has held steady since May, when it was unchanged from a Hold rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.41
Sales
$38.8M
Reporting Date
Aug 03

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.06%
 
 
 
 
 
 
Growthannually 27.37%
 
 
 
 
 
 

Sales

Growthquarterly 13.38%
 
 
 
 
 
 
Growthannually 5.01%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.